Haematuria. Unspecified haematuria
Conditions
Interventions
Intervention 1: For intervention group, We will administer 500 mg tranexamic acid (500mg/5cc, Tranexip, Caspiantamin Drug Group, Iran) in 500cc N/S for bladder irrigation. Intervention 2: For control
Treatment - Drugs
Placebo
For intervention group, We will administer 500 mg tranexamic acid (500mg/5cc, Tranexip, Caspiantamin Drug Group, Iran) in 500cc N/S for bladder irrigation.
For control group, we will use 500 cc N/S with 10 cc pure water as placebo for bladder irrigation.
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to 100 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria : (patient over 40 years old; lower urinary system bleeding like clot or fresh blood). Exclusion criteria : (pregnancy; lactation; history of thrombosis or thromboemboli; coagulopathy; history of myocardial infarction or ischemic stroke; renal failure; urinary tract infarction; disagreement to contribute to research)
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Haematuria. Timepoint: 0,1,3, and 24 hours. Method of measurement: Urinary test tape. | — |
Secondary
| Measure | Time frame |
|---|---|
| Haemoglobin. Timepoint: 0, 6, and 24 hours. Method of measurement: CBC Analysis. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyed Hossein Ojaghi Haghighi
Tabriz University of Medical Science
Outcome results
None listed